| Literature DB >> 26969251 |
Nadine Ladkau1, Miriam Assmann1, Manfred Schrewe2, Mattijs K Julsing1, Andreas Schmid3, Bruno Bühler4.
Abstract
The expansion of microbial substrate and product scopes will be an important brick promoting future bioeconomy. In this study, an orthogonal pathway running in parallel to native metabolism and converting renewable dodecanoic acid methyl ester (DAME) via terminal alcohol and aldehyde to 12-aminododecanoic acid methyl ester (ADAME), a building block for the high-performance polymer Nylon 12, was engineered in Escherichia coli and optimized regarding substrate uptake, substrate requirements, host strain choice, flux, and product yield. Efficient DAME uptake was achieved by means of the hydrophobic outer membrane porin AlkL increasing maximum oxygenation and transamination activities 8.3 and 7.6-fold, respectively. An optimized coupling to the pyruvate node via a heterologous alanine dehydrogenase enabled efficient intracellular L-alanine supply, a prerequisite for self-sufficient whole-cell transaminase catalysis. Finally, the introduction of a respiratory chain-linked alcohol dehydrogenase enabled an increase in pathway flux, the minimization of undesired overoxidation to the respective carboxylic acid, and thus the efficient formation of ADAME as main product. The completely synthetic orthogonal pathway presented in this study sets the stage for Nylon 12 production from renewables. Its effective operation achieved via fine tuning the connectivity to native cell functionalities emphasizes the potential of this concept to expand microbial substrate and product scopes.Entities:
Keywords: Dodecanedioic acid monomethyl ester (PubChem CID: 231998); In vivo cascade biocatalysis; Methyl 12-aminododecanoate (PubChem CID: 3665980); Methyl 12-hydroxydodecanoate (PubChem CID: 522424); Methyl dodecanoate (PubChem CID: 8139); Nylon 12; Orthogonal pathway engineering; Renewable plastics; Substrate uptake
Mesh:
Substances:
Year: 2016 PMID: 26969251 DOI: 10.1016/j.ymben.2016.02.011
Source DB: PubMed Journal: Metab Eng ISSN: 1096-7176 Impact factor: 9.783